Menus Subscribe Search

The Dutch Can Handle Their Pot

• September 16, 2011 • 11:42 AM

A researcher who compared the Netherlands’ marijuana use with that of other European countries and the U.S. finds the Dutch regime of tolerated small sales of cannabis does not lead to a drug free-for-all.

Since the 1970s, the Dutch have been famous among backpacking tourists, public health officials and drug-use researchers for their unusual national stance toward marijuana. Technically, the drug is illegal in the Netherlands. But the country has an official policy of non-enforcement, and you can buy the stuff — no more than 5 grams at a time — in hundreds of cannabis coffee shops.

This approach — somewhere in between all-out prohibition and free-market legalization — is like no other policy in Western Europe, or in the United States for that matter. But research reveals a surprising fact about Dutch tokers: The country’s drug policy may be remarkable, but very little about its users is.

“If you looked at all the data points in this paper, you wouldn’t be able to tell which ones were the Dutch,” said Robert MacCoun, a professor of public policy and law at the University of California, Berkeley, who has reported new findings in the journal Addiction. “The Dutch data are right in the middle of the distribution. There’s just nothing particularly distinctive about drug use in the Netherlands, which is interesting simply because many people assume that Dutch drug use must be out of control. And it’s not.”

[class name="dont_print_this"]

Idea Lobby

THE IDEA LOBBY
Miller-McCune's Washington correspondent Emily Badger follows the ideas informing, explaining and influencing government, from the local think tank circuit to academic research that shapes D.C. policy from afar.

[/class]

Not only is it not out of control, but people who smoke pot in the Netherlands are less likely to escalate their use — into a heavier habit or harder drugs — than they are in the U.S., and they tend to mature out of marijuana faster than American users do.

This evidence suggests an intriguing alternative path for U.S. policy. Dutch officials condoned cannabis coffee shops on the theory that they would help “separate the market” between marijuana and harder drugs. Give people a place to legally buy pot in limited quantities, officials figured, and they won’t have to go to a shady street corner where sellers are also pushing cocaine or heroin.

“What I see in the data is support for the idea that that actually worked,” MacCoun said. (Although it may soon only work for Dutch nationals. This spring the government proposed cutting out the drug tourism industry by converting coffee shops into private clubs for citizens only.) The coffee shops may have modestly increased marijuana use in the Netherlands, even as MacCoun’s research suggests that use doesn’t necessarily lead to more serious public health challenges. Use has slightly risen and fallen over time alongside the prevalence of retail outlets. Since the mid-1990s, the number of shops has dropped by about 40 percent, to around 700 now (or 1 per every 3,000 citizens in heavily concentrated Amsterdam). Since 1997, officials have been stricter in shutting down shops that violate basic requirements. They can’t allow in children under 18, they can’t sell any other drugs, and they can’t advertise marijuana. (But having Bob Marley on your sign is OK.)

This last requirement is a key one: You can buy pot in the Netherlands, but you won’t see billboards or bus advertisements suggesting you run right out and do this. And this may be one of the complications of testing such a quasi-legal policy in the U.S., where First Amendment protections for commercial speech are much stronger than they are in most countries. Once a product is legal here, it’s hard to curtail what companies can say about it (a lesson the government is currently learning with tobacco companies).

“But mostly I think we can’t afford to ignore lessons form abroad,” MacCoun said. “We can’t afford to be provincial about this because we’ll never learn anything about how to make better policy unless we actually study countries that are trying different things.”

MacCoun has followed Dutch drug policy in his research for more than a decade. But comparable data on drug use, enforcement and treatment in other European countries is now making it possible for the first time compare Dutch outcomes not just with the United States, but also with the country’s immediate (and more culturally similar) neighbors.

This latest data supports a theme MacCoun’s work has long highlighted: the potential for middle-ground drug-policy solutions that toe the line between legalization and enforced prohibition. Current discussion in the U.S., though, seldom strays from that dichotomy.

“I do think the debate has gotten unhelpfully polarized so that any talk about criticizing current policies is seen as an automatic endorsement of going to the opposite extreme, of going to the free-market, libertarian model,” he said. Where middle-ground alternatives like needle exchange come up, they’re often criticized as a Trojan horse for eventual legalization. “That’s a really unhelpful way to categorize it,” MacCoun said.

“There’s a whole range of things you could do in between those two extremes.”

Sign up for the free Miller-McCune.com e-newsletter.

“Like” Miller-McCune on Facebook.

Follow Miller-McCune on Twitter.

Add Miller-McCune.com news to your site.

Subscribe to Miller-McCune

Emily Badger
Emily Badger is a freelance writer living in the Washington, D.C. area who has contributed to The New York Times, International Herald Tribune and The Christian Science Monitor. She previously covered college sports for the Orlando Sentinel and lived and reported in France.

More From Emily Badger

A weekly roundup of the best of Pacific Standard and PSmag.com, delivered straight to your inbox.

Recent Posts

July 24 • 12:00 PM

What’s in a Name? The Problem With Washington’s Football Team

A senior advisor to the National Congress of American Indians once threw an embarrassing themed party that involved headdresses. He regrets that costume now, but knows his experience is one many others can relate to.


July 24 • 11:00 AM

How Wildlife Declines Are Leading to Slavery and Terrorism

As wildlife numbers dwindle, wildlife crimes are rising—and that’s fueling a raft of heinous crimes committed against humans.


July 24 • 10:58 AM

How the Supremes Pick Their Cases—and Why Obamacare Is Safe for Now

The opponents of Obamacare who went one for two in circuit court rulings earlier this week are unlikely to see their cases reach the Supreme Court.



July 24 • 9:48 AM

The People Who Are Scared of Dogs

While more people fear snakes or spiders, with dogs everywhere, cynophobia makes everyday public life a constant challenge.


July 24 • 8:00 AM

Newton’s Needle: On Scientific Self-Experimentation

It is all too easy to treat science as a platform that allows the observer to hover over the messiness of life, unobserved and untouched. But by remembering the role of the body in science, perhaps we humanize it as well.


July 24 • 6:00 AM

Commercializing the Counterculture: How the Summer Music Festival Went Mainstream

With painted Volkswagen buses, talk of “free love,” and other reminders of the Woodstock era replaced by advertising and corporate sponsorships, hippie culture may be dying, but a new subculture—a sort of purgatory between hipster and hippie—is on the rise.


July 24 • 5:00 AM

In Praise of Our Short Attention Spans

Maybe there’s a good reason why it seems like there’s been a decline in our our ability to concentrate for a prolonged period of time.


July 24 • 4:00 AM

How Stereotypes Take Shape

New research from Scotland finds they’re an unfortunate product of the way we process and share information.


July 23 • 4:00 PM

Who Doesn’t Like Atheists?

The Pew Research Center asked Americans of varying religious affiliations how they felt about each other.


July 23 • 2:00 PM

We Need to Start Tracking Patient Harm and Medical Mistakes Now

Top patient-safety experts call on Congress to step in and, among other steps, give the Centers for Disease Control and Prevention wider responsibility for measuring medical mistakes.


July 23 • 12:19 PM

How a CEO’s Fiery Battle Speeches Can Shape Ethical Behavior

CEO war speech might inspire ethical decisions internally and unethical ones among competing companies.


July 23 • 12:00 PM

Why Do We Love the ‘Kim Kardashian: Hollywood’ Game?

It’s easy enough to turn yourself into a virtual celebrity, complete with fame and mansions—but it will likely cost you.


July 23 • 11:49 AM

Modern Technology Still Doesn’t Protect Americans From Deadly Landslides

No landslide monitoring or warning systems are being used to protect vulnerable communities.


July 23 • 10:00 AM

Outing the Death-Drug Distributors

Calling all hackers: It’s time to go Assange on capital punishment.


July 23 • 8:00 AM

The Surprising Appeal of Products That Require Effort to Use

New research finds they enable consumers to re-establish a feeling that they’re in control of their lives.



July 23 • 6:00 AM

How the Other Half Lifts: What Your Workout Says About Your Social Class

Why can’t triathletes and weightlifters get along?


July 23 • 5:02 AM

Battle of the Public Intellectuals: Edward Glaeser vs. Richard Florida

On gentrification and housing costs.


July 23 • 4:00 AM

Our Fear of Immigrants

Why did a group of fourth graders rally in support of an undocumented classmate while the citizens of Murrieta, California, tried to stop immigrant children from entering their town?


July 22 • 4:00 PM

Can Meditation Really Slow Aging?

Is there real science in the spiritualism of meditation? Jo Marchant meets a Nobel Prize-winner who thinks so.



July 22 • 2:00 PM

The Alabama Judge Who Refuses to Let Desegregation Orders Go Ignored

A federal judge in Alabama says a local school board has failed to meet legal mandate to integrate.


July 22 • 12:00 PM

On the Destinations of Species

It’s almost always easier to cross international borders if you’re something other than human.


July 22 • 10:51 AM

The Link Between Carbs, Gut Microbes, and Colon Cancer

Reduced carb intake among mice protected them from colon cancer.


Follow us


Subscribe Now

How Wildlife Declines Are Leading to Slavery and Terrorism

As wildlife numbers dwindle, wildlife crimes are rising—and that's fueling a raft of heinous crimes committed against humans.

How a CEO’s Fiery Battle Speeches Can Shape Ethical Behavior

CEO war speech might inspire ethical decisions internally and unethical ones among competing companies.

Modern Technology Still Doesn’t Protect Americans From Deadly Landslides

No landslide monitoring or warning systems are being used to protect vulnerable communities.

The Link Between Carbs, Gut Microbes, and Colon Cancer

Reduced carb intake among mice protected them from colon cancer.

The New Weapon Against Disease-Spreading Insects Is Big Data

Computer models that pinpoint the likely locations of mosquitoes and tsetse flies are helping officials target vector control efforts.

The Big One

Today, the United States produces less than two percent of the clothing purchased by Americans. In 1990, it produced nearly 50 percent. July/August 2014

Copyright © 2014 by Pacific Standard and The Miller-McCune Center for Research, Media, and Public Policy. All Rights Reserved.